Advancing drug development by leveraging microdissection for proteogenomic analysis of histological sections. Pathological evaluation of tumor immune microenvironment before first-line anti-PD1 plus ...
Adjuvant capecitabine treatment for stage III colon cancer in Japanese patients (KSCC0803). Phase II trial of cetuximab plus irinotecan for FOLFOX and FOLFIRI-refractory patients with EGFR-positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results